Antibody–Drug Conjugates—A Tutorial Review

Antibody–drug conjugates (ADCs) are a family of targeted therapeutic agents for the treatment of cancer. ADC development is a rapidly expanding field of research, with over 80 ADCs currently in clinical development and eleven ADCs (nine containing small-molecule payloads and two with biological toxi...

Descripción completa

Detalles Bibliográficos
Autores principales: Baah, Stephanie, Laws, Mark, Rahman, Khondaker Miraz
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8156828/
https://www.ncbi.nlm.nih.gov/pubmed/34063364
http://dx.doi.org/10.3390/molecules26102943

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8156828/
https://www.ncbi.nlm.nih.gov/pubmed/34063364
http://dx.doi.org/10.3390/molecules26102943

Ejemplares similares